Amy Dewar

2.2k total citations · 1 hit paper
11 papers, 338 citations indexed

About

Amy Dewar is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Infectious Diseases. According to data from OpenAlex, Amy Dewar has authored 11 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Neurology and 2 papers in Infectious Diseases. Recurrent topics in Amy Dewar's work include Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Respiratory Support and Mechanisms (3 papers) and COVID-19 Clinical Research Studies (2 papers). Amy Dewar is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Respiratory Support and Mechanisms (3 papers) and COVID-19 Clinical Research Studies (2 papers). Amy Dewar collaborates with scholars based in United Kingdom, Netherlands and Canada. Amy Dewar's co-authors include Alex West, Bhashkar Mukherjee, Katherine Myall, Muhunthan Thillai, Philip L. Molyneaux, Giulia Benedetti, Rebecca Preston, Sze Mun Mak, K. G. M. M. Alberti and G.F. Batstone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Thorax and BMC Medicine.

In The Last Decade

Amy Dewar

10 papers receiving 322 citations

Hit Papers

Persistent Post–COVID-19 Interstitial Lung Disease. An Ob... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Dewar United Kingdom 5 218 162 150 43 40 11 338
Katherine Myall United Kingdom 7 224 1.0× 175 1.1× 183 1.2× 43 1.0× 39 1.0× 20 376
Erica Thwaite United Kingdom 4 178 0.8× 144 0.9× 165 1.1× 47 1.1× 57 1.4× 5 337
Bernt B. Aarli Norway 8 221 1.0× 119 0.7× 206 1.4× 70 1.6× 66 1.6× 14 392
Bavithra Vijayakumar United Kingdom 6 158 0.7× 123 0.8× 105 0.7× 40 0.9× 47 1.2× 17 284
Mabel Tong China 4 286 1.3× 178 1.1× 119 0.8× 104 2.4× 86 2.1× 5 431
Gianluca Imeri Italy 7 154 0.7× 84 0.5× 146 1.0× 52 1.2× 91 2.3× 22 337
Sabina Sahanic Austria 10 233 1.1× 224 1.4× 73 0.5× 87 2.0× 79 2.0× 20 428
Daniele Colombo Italy 9 91 0.4× 61 0.4× 221 1.5× 30 0.7× 105 2.6× 17 370
Carin Meltzer Norway 4 199 0.9× 108 0.7× 105 0.7× 62 1.4× 63 1.6× 8 251
Tøri Vigeland Lerum Norway 7 330 1.5× 143 0.9× 139 0.9× 99 2.3× 94 2.4× 11 399

Countries citing papers authored by Amy Dewar

Since Specialization
Citations

This map shows the geographic impact of Amy Dewar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Dewar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Dewar more than expected).

Fields of papers citing papers by Amy Dewar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Dewar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Dewar. The network helps show where Amy Dewar may publish in the future.

Co-authorship network of co-authors of Amy Dewar

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Dewar. A scholar is included among the top collaborators of Amy Dewar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Dewar. Amy Dewar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Patel, Irem, Ann McNeill, John Moxham, et al.. (2024). Evaluation of a hospital-initiated tobacco dependence treatment service: uptake, smoking cessation, readmission and mortality. BMC Medicine. 22(1). 139–139. 1 indexed citations
3.
Dewar, Amy, Nicholas Tetlow, Robert Stephens, & John Whittle. (2023). The Duke Activity Status Index compared with cardiopulmonary exercise testing in patients undergoing pre‐operative assessment for cancer surgery. Anaesthesia. 78(12). 1505–1506. 1 indexed citations
4.
Tetlow, Nicholas, et al.. (2022). Implementation of a surgical prehabilitation pathway at a tertiary surgical centre during a global pandemic. SHILAP Revista de lepidopterología. 4. 100069–100069. 1 indexed citations
5.
D’Cruz, Rebecca, Eui‐Sik Suh, Georgios Kaltsakas, et al.. (2021). Home parasternal electromyography tracks patient-reported and physiological measures of recovery from severe COPD exacerbation. ERJ Open Research. 7(2). 709–2020. 7 indexed citations
6.
Myall, Katherine, Bhashkar Mukherjee, Giulia Benedetti, et al.. (2021). Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Annals of the American Thoracic Society. 18(5). 799–806. 264 indexed citations breakdown →
7.
Myall, Katherine, et al.. (2021). Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax. 76(4). 408–411. 34 indexed citations
8.
D’Cruz, Rebecca, Anne Rossel, Eui‐Sik Suh, et al.. (2021). Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial. OA1626–OA1626. 1 indexed citations
9.
Dewar, Amy, et al.. (2020). Can a COPD pharmacist reduce out-patient clinic non-attendance rates?. 838–838. 1 indexed citations
10.
Dewar, Amy. (2003). Testing the effectiveness of a nursing intervention in relieving pain following day surgery. Ambulatory Surgery. 10(2). 81–88. 20 indexed citations
11.
Batstone, G.F., K. G. M. M. Alberti, & Amy Dewar. (1977). Reversible lactic acidosis associated with repeated intravenous infusions of sorbitol and ethanol. Postgraduate Medical Journal. 53(623). 567–569. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026